OBJECTIVES: To determine if intraperitoneally (IP) administered contrast (iohexol), used in conjunction with a liver-specific agent (Fenestra), can improve measurement precision and accuracy when quantifying tumor volume from micro-CT images of a liver metastasis model. MATERIALS AND METHODS: We compared images acquired with Fenestra alone to images acquired with the combination of Fenestra and IP iohexol. The variability in tumor volume and tumor-burden measurement was evaluated for both techniques. The tumor-burden measurement accuracy of both in vivo techniques was determined by comparison with tumor-burden quantified from ex vivo images. RESULTS: : The addition of IP iohexol decreased measurement variability for individual tumors and overall tumor-burden by 4-8 fold and 2-3 fold, respectively. IP iohexol significantly improved the accuracy of tumor-burden measurement for both low and high tumor-burdened animals. CONCLUSIONS: The combination of IP iohexol with Fenestra provides superior delineation of liver tumors, in comparison to Fenestra alone. The complete tumor delineation provided by this imaging strategy allows for noninvasive quantification of liver tumor-burden.
OBJECTIVES: To determine if intraperitoneally (IP) administered contrast (iohexol), used in conjunction with a liver-specific agent (Fenestra), can improve measurement precision and accuracy when quantifying tumor volume from micro-CT images of a liver metastasis model. MATERIALS AND METHODS: We compared images acquired with Fenestra alone to images acquired with the combination of Fenestra and IP iohexol. The variability in tumor volume and tumor-burden measurement was evaluated for both techniques. The tumor-burden measurement accuracy of both in vivo techniques was determined by comparison with tumor-burden quantified from ex vivo images. RESULTS: : The addition of IP iohexol decreased measurement variability for individual tumors and overall tumor-burden by 4-8 fold and 2-3 fold, respectively. IP iohexol significantly improved the accuracy of tumor-burden measurement for both low and high tumor-burdened animals. CONCLUSIONS: The combination of IP iohexol with Fenestra provides superior delineation of liver tumors, in comparison to Fenestra alone. The complete tumor delineation provided by this imaging strategy allows for noninvasive quantification of liver tumor-burden.
Authors: Angelique Ale; Vladimir Ermolayev; Eva Herzog; Christian Cohrs; Martin Hrabé de Angelis; Vasilis Ntziachristos Journal: Nat Methods Date: 2012-05-06 Impact factor: 28.547
Authors: Gurpreet Singh Sandhu; Luis Solorio; Ann-Marie Broome; Nicolas Salem; Jeff Kolthammer; Tejas Shah; Chris Flask; Jeffrey L Duerk Journal: Wiley Interdiscip Rev Syst Biol Med Date: 2010 Jul-Aug
Authors: Daniel L J Thorek; Robin M Kramer; Qing Chen; Jeho Jeong; Mihaela E Lupu; Alycia M Lee; Mary E Moynahan; Maeve Lowery; David Ulmert; Pat Zanzonico; Joseph O Deasy; John L Humm; James Russell Journal: Int J Radiat Oncol Biol Phys Date: 2015-06-09 Impact factor: 7.038
Authors: Hanne Boll; Stefanie Nittka; Fabian Doyon; Michael Neumaier; Alexander Marx; Martin Kramer; Christoph Groden; Marc A Brockmann Journal: PLoS One Date: 2011-09-30 Impact factor: 3.240
Authors: Teresa Fiebig; Hanne Boll; Giovanna Figueiredo; Hans Ulrich Kerl; Stefanie Nittka; Christoph Groden; Martin Kramer; Marc A Brockmann Journal: PLoS One Date: 2012-02-08 Impact factor: 3.240